Trials / Completed
CompletedNCT03906019
Indications of Erector Spinae Plane Block in Pediatric Patients
Defining the Indications and Levels of Erector Spinae Plane Block in Pediatric Patients: A Retrospective Study About Our Current Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 141 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- —
Summary
Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned.
Detailed description
There are a few randomized prospective studies of ESPB for its clinical effectiveness and all of them are in adults, except one. Also pediatric case reports are limited when compared to adults. We have been applying ESPB to our patients almost since from its first definition. But ESPB applications for pediatric patients, in our clinic, have started after a learning curve. Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned. Demographical data of the patient, patient position for the block, indication/surgery type, level of ESPB, unilateral or bilateral application, total volume applied, additional analgesic use, type of the analgesic if used will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ESP Block | Erector spinae plane block performed with 0,25% bupivacaine (0,5 mL/kg-max 20mL), under general anesthesia before the start of the surgery. |
| DIAGNOSTIC_TEST | FLACC score | For up to 7 years old patients, Face, Legs, Activity, Cry and Consolability (FLACC) scores during postoperative 24h period. |
| DIAGNOSTIC_TEST | NRS score | Patients older than 7 years, NRS scores during postoperative 24h period. |
Timeline
- Start date
- 2019-04-09
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2019-04-08
- Last updated
- 2019-08-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03906019. Inclusion in this directory is not an endorsement.